Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells

Overview of attention for article published in Frontiers in Pharmacology, November 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,841 followers.

Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation. Would this also help in Type 1? @NIH @Nirtek_PtyLtd @mdelibeg @ClevelandClinic @MGHGlobalHealth @CedarsSinai @Amgen @AstraZeneca @LillyPadEU @Boehringer http

04 Apr 2024

Reply Repost Favourite

New Research: Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells https://t.co/7aqKS4zcb2 #pharmacology

29 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.